Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (131-140 of 401) with videos related to

Pageof 41
Sort By:
Platelets|November 15, 2012
Near patient anti-platelet response testing over time and gene analysis in patients admitted with acute coronary syndromesVincent Amoah, Robert F Storey, Andrew P Worrall, et al.
Diabetes & Vascular Disease Research|October 21, 2020
Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarctionColin C Everett, Catherine Reynolds, Catherine Fernandez, et al.
Platelets|June 1, 2018
Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) studyWilliam A E Parker, Niclas Eriksson, Richard C Becker, et al.
Platelets|October 12, 2013
Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromesRajiv R Joshi, Rashed Hossain, Allison C Morton, et al.
Stroke|April 11, 2013
Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trialsStefan K James, Karen S Pieper, Christopher P Cannon, et al.
Thrombosis and Haemostasis|June 28, 2013
Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery diseaseDorothee Kaudewitz, Regent Lee, Peter Willeit, et al.
The American Journal of Medicine|March 31, 2015
Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sexNaji Kholaif, Yinggan Zheng, Pushpa Jagasia, et al.
American Heart Journal|March 25, 2014
Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trialMarc P Bonaca, Deepak L Bhatt, Eugene Braunwald, et al.
Platelets|January 3, 2020
Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptakeKok Weng Ow, William A E Parker, Mark M Porter, et al.
Thrombosis and Haemostasis|July 5, 2022
Resumption of Antiplatelet Therapy after Major BleedingTobias Geisler, Sven Poli, Kurt Huber, et al.
Pageof 41

Showing results (131-140 of 401) with videos related to

Sort By:
Pageof 41
Platelets|November 15, 2012
Near patient anti-platelet response testing over time and gene analysis in patients admitted with acute coronary syndromesVincent Amoah, Robert F Storey, Andrew P Worrall, et al.
Diabetes & Vascular Disease Research|October 21, 2020
Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarctionColin C Everett, Catherine Reynolds, Catherine Fernandez, et al.
Platelets|June 1, 2018
Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) studyWilliam A E Parker, Niclas Eriksson, Richard C Becker, et al.
Platelets|October 12, 2013
Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromesRajiv R Joshi, Rashed Hossain, Allison C Morton, et al.
Stroke|April 11, 2013
Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trialsStefan K James, Karen S Pieper, Christopher P Cannon, et al.
Thrombosis and Haemostasis|June 28, 2013
Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery diseaseDorothee Kaudewitz, Regent Lee, Peter Willeit, et al.
The American Journal of Medicine|March 31, 2015
Baseline Q waves and time from symptom onset to ST-segment elevation myocardial infarction: insights from PLATO on the influence of sexNaji Kholaif, Yinggan Zheng, Pushpa Jagasia, et al.
American Heart Journal|March 25, 2014
Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trialMarc P Bonaca, Deepak L Bhatt, Eugene Braunwald, et al.
Platelets|January 3, 2020
Offset of ticagrelor prior to coronary artery bypass graft surgery for acute coronary syndromes: effects on platelet function and cellular adenosine uptakeKok Weng Ow, William A E Parker, Mark M Porter, et al.
Thrombosis and Haemostasis|July 5, 2022
Resumption of Antiplatelet Therapy after Major BleedingTobias Geisler, Sven Poli, Kurt Huber, et al.
Pageof 41